- Home
- STTK vs ARKR Comparison
STTK vs ARKR Comparison
Compare STTK & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- ARKR
- Stock Information
- Founded
- STTK 2016
- ARKR 1983
- Country
- STTK United States
- ARKR United States
- Employees
- STTK N/A
- ARKR N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- ARKR Restaurants
- Sector
- STTK Health Care
- ARKR Consumer Discretionary
- Exchange
- STTK Nasdaq
- ARKR Nasdaq
- Market Cap
- STTK 37.6M
- ARKR 44.3M
- IPO Year
- STTK 2020
- ARKR N/A
- Fundamental
- Price
- STTK $1.14
- ARKR $10.25
- Analyst Decision
- STTK Hold
- ARKR
- Analyst Count
- STTK 4
- ARKR 0
- Target Price
- STTK $3.00
- ARKR N/A
- AVG Volume (30 Days)
- STTK 101.1K
- ARKR 5.2K
- Earning Date
- STTK 07-31-2025
- ARKR 05-12-2025
- Dividend Yield
- STTK N/A
- ARKR N/A
- EPS Growth
- STTK N/A
- ARKR N/A
- EPS
- STTK N/A
- ARKR N/A
- Revenue
- STTK $4,606,000.00
- ARKR $178,516,000.00
- Revenue This Year
- STTK N/A
- ARKR N/A
- Revenue Next Year
- STTK N/A
- ARKR N/A
- P/E Ratio
- STTK N/A
- ARKR N/A
- Revenue Growth
- STTK 69.65
- ARKR N/A
- 52 Week Low
- STTK $0.69
- ARKR $8.25
- 52 Week High
- STTK $7.49
- ARKR $17.76
- Technical
- Relative Strength Index (RSI)
- STTK 56.02
- ARKR 43.24
- Support Level
- STTK $0.98
- ARKR $10.20
- Resistance Level
- STTK $1.13
- ARKR $12.44
- Average True Range (ATR)
- STTK 0.10
- ARKR 0.62
- MACD
- STTK 0.01
- ARKR -0.24
- Stochastic Oscillator
- STTK 84.85
- ARKR 24.19
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
About ARKR Ark Restaurants Corp.
Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.